- Home
- BAND vs HRTX Comparison
BAND vs HRTX Comparison
Compare BAND & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAND
- HRTX
- Stock Information
- Founded
- BAND 2000
- HRTX 1983
- Country
- BAND United States
- HRTX United States
- Employees
- BAND N/A
- HRTX N/A
- Industry
- BAND Computer Software: Prepackaged Software
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- BAND Technology
- HRTX Health Care
- Exchange
- BAND Nasdaq
- HRTX Nasdaq
- Market Cap
- BAND 358.3M
- HRTX 325.0M
- IPO Year
- BAND 2017
- HRTX 1987
- Fundamental
- Price
- BAND $14.72
- HRTX $2.03
- Analyst Decision
- BAND Hold
- HRTX Strong Buy
- Analyst Count
- BAND 5
- HRTX 2
- Target Price
- BAND $21.00
- HRTX $5.50
- AVG Volume (30 Days)
- BAND 280.0K
- HRTX 1.7M
- Earning Date
- BAND 05-07-2025
- HRTX 05-06-2025
- Dividend Yield
- BAND N/A
- HRTX N/A
- EPS Growth
- BAND N/A
- HRTX N/A
- EPS
- BAND N/A
- HRTX N/A
- Revenue
- BAND $751,695,000.00
- HRTX $148,518,000.00
- Revenue This Year
- BAND $2.35
- HRTX $12.60
- Revenue Next Year
- BAND $12.94
- HRTX $13.66
- P/E Ratio
- BAND N/A
- HRTX N/A
- Revenue Growth
- BAND 18.51
- HRTX 12.43
- 52 Week Low
- BAND $11.33
- HRTX $1.04
- 52 Week High
- BAND $23.90
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- BAND 59.93
- HRTX 52.38
- Support Level
- BAND $13.77
- HRTX $1.82
- Resistance Level
- BAND $14.89
- HRTX $1.93
- Average True Range (ATR)
- BAND 0.48
- HRTX 0.09
- MACD
- BAND 0.02
- HRTX 0.02
- Stochastic Oscillator
- BAND 87.12
- HRTX 91.71
About BAND Bandwidth Inc.
Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of our revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.